Related Experiment Video

Updated: Aug 20, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Pain, plasticity, and premature birth: a prescription for permanent suffering?

K J Anand

    Nature Medicine
    |September 6, 2000
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
    06:19

    A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

    Published on: January 7, 2018

    A Preterm Rat Model for Pain Studies
    01:37

    A Preterm Rat Model for Pain Studies

    Published on: February 9, 2024

    Related Experiment Videos

    Last Updated: Aug 20, 2026

    Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
    07:36

    Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

    Published on: November 20, 2015

    A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
    06:19

    A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

    Published on: January 7, 2018

    A Preterm Rat Model for Pain Studies
    01:37

    A Preterm Rat Model for Pain Studies

    Published on: February 9, 2024

    Related Concept Videos

    Long-term Potentiation01:35

    Long-term Potentiation

    Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
    Neuroplasticity01:01

    Neuroplasticity

    Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.

    Articles linked to this work by shared authors, journal, and citation graph.

    Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response.

    Lancet (London, England)·2010

    Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence.

    Brain research. Brain research reviews·2001

    Hormonal and metabolic stress responses after major surgery in children aged 0-3 years: a double-blind, randomized trial comparing the effects of continuous versus intermittent morphine.

    British journal of anaesthesia·2001

    Statistical models to predict the need for postoperative intensive care and hospitalization in pediatric surgical patients.

    Intensive care medicine·2001

    Interactions of inflammatory pain and morphine in infant rats: long-term behavioral effects.

    Physiology & behavior·2001

    Abnormal cognition and behavior in preterm neonates linked to smaller brain volumes.

    Trends in neurosciences·2001

    Inhaled siRNA therapy targeting RAGE for pulmonary inflammation: a first-in-human randomized trial.

    Nature medicine·2026

    Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial.

    Nature medicine·2026

    Isthmin-2 is a first-trimester predictor of preeclampsia and fetal growth restriction.

    Nature medicine·2026

    Antifungal therapy improves microbiome dynamics in inflammatory bowel disease.

    Nature medicine·2026

    Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial.

    Nature medicine·2026

    Short-term effects of combinations of heart failure therapies on blood pressure, kidney function and serum potassium.

    Nature medicine·2026

    Culturally adapted post-diagnostic dementia support for South Asian people living with dementia and caregivers: a rapid review.

    Age and ageing·2026

    Relationship Between EAT-10 Scores, Pharyngeal Residue Severity, and Penetration-Aspiration in Individuals With Idiopathic Parkinson's Disease: A FEES-Based Correlation and Discriminative Performance Study.

    International journal of language & communication disorders·2026

    Dilated Gallbladder Causing Right Iliac Fossa Pain in a Patient with Advanced Pancreatic Cancer: A Diagnostic and Symptom Management Challenge at End of Life.

    Palliative medicine reports·2026

    Barriers and Facilitators in Access to Care Among Adults With Traumatic Spinal Cord Injuries: A Qualitative Study Comparing VA and Commercial Insurance.

    Health services insights·2026

    Sex-related differences in the physical, functional, physiological, and emotional profile of adults with chronic vestibular hypofunction: a cross-sectional EXERVEST study.

    Frontiers in rehabilitation sciences·2026

    Pyrroloquinoline Quinone Attenuates Traumatic Brain Injury-Induced Secondary Damage by Activating PINK1/Parkin-Mediated Mitophagy and Suppressing ASS1/CPS1-Driven Arginine Biosynthesis.

    CNS neuroscience & therapeutics·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us